Korean J Med > Volume 70(2); 2006 > Article
The Korean Journal of Medicine 2006;70(2):302-308.
Case Reports : A case of malignant fibrous histiocytoma with durable response by chemotherapy and thalidomide
Sang-Hoon Jun
한림의대 한강성심병원 내과
증례 : 항암화학요법과 탈리도아미드에 반응을 보인 악성섬유조직구종 1예
전상훈
Abstract
Cardiac malignant fibrous histiocytoma are extremely rare and the prognosis is reported to be very poor. Here, we report a case of cardiac malignant fibrous histiocytoma with durable response by chemotherapy and thalidomide. A 35-year-old woman with sudden onset of dyspnea and chest pain was diagnosed with cardiac tumor. The tumor was removed by a supra-septal approach of open-heart surgery, and immunohistochemical staining revealed the malignant fibrous histiocytoma. However, we found the tumor recurrence at right atrium after 3 months. She was treated with systemic chemotherapy, and had partial response with significant treatment-related toxicities after 5-cycle chemotherapy. So we decided to do supportive care and thalidomide therapy, which is interested in studying as an anti-angiogenic agent recently. At present, patient still keep alive without the progression of disease for 18 months.(Korean J Med 70:S302-S308, 2006) Key Words : Malignant fibrous histiocytoma, Thalidomide


TOOLS
METRICS Graph View
  • 704 View
  • 4 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next